Isolation and characterization of dominant and recessive IL-3-independent hematopoietic transformants
- PMID: 16702946
- DOI: 10.1038/sj.onc.1209673
Isolation and characterization of dominant and recessive IL-3-independent hematopoietic transformants
Abstract
Retroviral integration mutagenesis and treatment with the frameshift mutagen ICR191 were used to transform v-H-ras expressing PB-3c cells to interleukin-3 (IL-3) independence. Six clones displayed viral integrations into the 3' region of the IL-3 gene thus acting post-transcriptionally by disrupting the AU-rich instability element. Two clones contained reverse orientation integration into the raf-1 gene revealing an enhancer insertion mechanism. Growth by this mechanism was sensitive to the Raf-1 inhibitor BAY 43-9006 and the Mek inhibitor U0126. Following treatment with ICR191, IL-3-independent clones were recovered and studied by cell fusion. With 21/22 clones, IL-3 independence resulted from a recessive mechanism as cellular hybrids with parental cells reverted to IL-3 dependence. Recessive clone D2c displayed increased phospho-Erk1/2 levels and was growth sensitive to U0126, but not to BAY43-9006. The single dominant clone, D5a, showed no signs of mitogen-activated protein kinases pathway activation but displayed constitutive phosphorylation of Stat5. We conclude that PB-3c has several options to acquire IL-3 growth autonomy involving transcriptional or post-transcriptional mechanisms affecting the distal regulators Erk or Stat5. The reported panel of independent dominant and recessive transformants should provide a useful tool for inhibitor profiling.
Similar articles
-
Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.J Pharmacol Exp Ther. 2009 Jun;329(3):1063-70. doi: 10.1124/jpet.108.147306. Epub 2009 Mar 3. J Pharmacol Exp Ther. 2009. PMID: 19258520
-
V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.Exp Hematol. 1997 May;25(5):395-404. Exp Hematol. 1997. PMID: 9168061
-
Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.J Cell Physiol. 2009 Jul;220(1):214-21. doi: 10.1002/jcp.21753. J Cell Physiol. 2009. PMID: 19288493
-
Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.Oncogene. 2007 Feb 8;26(6):813-21. doi: 10.1038/sj.onc.1209843. Epub 2006 Aug 7. Oncogene. 2007. PMID: 16909118
-
Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.Semin Oncol. 2006 Aug;33(4):392-406. doi: 10.1053/j.seminoncol.2006.04.002. Semin Oncol. 2006. PMID: 16890795 Review.
Cited by
-
The hepatitis C viral nonstructural protein 5A stabilizes growth-regulatory human transcripts.Nucleic Acids Res. 2018 Mar 16;46(5):2537-2547. doi: 10.1093/nar/gky061. Nucleic Acids Res. 2018. PMID: 29385522 Free PMC article.
-
Anti-apoptotic function of Xbp1 as an IL-3 signaling molecule in hematopoietic cells.Cell Death Dis. 2011 Feb 10;2(2):e118. doi: 10.1038/cddis.2011.1. Cell Death Dis. 2011. PMID: 21368889 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous